Navigation Links
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
Date:5/12/2008

ount); var hd1 = document.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >IOMI) announced today that they have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for USD 6.60 per share representing a fully diluted equity value of approximately USD 189 million (EUR 122 million). The transaction has been unanimously approved by the Boards of Directors of both companies and is subject to customary closing conditions including antitrust clearances, clearance by the Committee on Foreign Investment in the United States and the approval of the holders of a majority of Iomai's shares. Shareholders holding over 50 percent of Iomai's total shares outstanding have entered into agreements to vote in favour of the combination.

Intercell will gain full rights to Iomai's late stage Travelers' Diarrhea vaccine which is based on Iomai's proprietary needle-free patch delivery vaccine technology and has shown positive interim Phase II efficacy data. The Travelers' Diarrhea vaccine is expected to enter pivotal Phase III trials in the first half of 2009. If approved, the medical use of Iomai's Travelers' Diarrhea vaccine will be highly complementary with Intercell's Japanese Encephalitis vaccine for which a Biologics License Application was successfully submitted to the US Food and Drug Administration in December 2007, and for which Intercell expects market approvals in the US, Europe and Australia in 2008. Together, both vaccines create an extremely attractive Traveler's Vaccine franchise which will target a combined market opportunity of over USD 1 billion in sales per year.

Commenting on the transaction, Gerd Zettlmeissl, CEO of Intercell, said: "This transaction further expands our leadership in vaccine innovation, greatly enhances Intercell's R&D technology base and further strengthens our late stage vaccine portfolio. Building on our proven experience in industrialization and in moving novel products t
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
3. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
11. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
(Date:8/29/2014)... -- Research and Markets has announced the ... 2014-2017" report to their offering. ... reimbursement for medical expenses, the Chinese orthopedic instrument market ... a CAGR of 19.2% during 2009-2013. Trauma products, spine ... orthopedic instruments in China , of ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... , PITTSBURGH , Feb. 4 ... was sued by Pfizer in connection with the filing of an ... Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, ... mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg. This product ...
... Calif. , Feb. 4 Imagine having to ... medications a day to manage a chronic health condition; add ... incorrectly. For Anthem Blue Cross (Anthem) Medi-Cal members, that daily ... and reduce medication errors. , Anthem will now offer ...
Cached Medicine Technology:Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R) 2Medi-Cal Members Reduce Potential for Medication Error with Innovative Program 2Medi-Cal Members Reduce Potential for Medication Error with Innovative Program 3
(Date:8/30/2014)... 2014: The first expert consensus on ventricular arrhythmias ... evidence on the diagnosis and management of ventricular ... three continents. , The "EHRA/HRS/APHRS Expert Consensus on ... EP Europace (1). It was written jointly ... the European Society of Cardiology (ESC), the Heart ...
(Date:8/30/2014)... 30 August 2014: The first recommendations on the ... embolism are published today in new ESC Guidelines. ... Professor Stavros V. Konstantinides (Germany/Greece) and Professor Adam ... the diagnosis and management of acute pulmonary embolism" ... (1) and on the ESC Website. , Venous ...
(Date:8/30/2014)... August 2014: The therapeutic benefit of revascularisation in ... 2014 ESC/EACTS revascularisation guidelines presented at ESC Congress ... (Switzerland) of the European Society of Cardiology (ESC) ... Association for Cardio-Thoracic Surgery (EACTS). The joint guidelines ... Journal (1), on the ESC Website (2), ...
(Date:8/29/2014)... The Enchant Him review that was recently published by ... system that promises to teach ladies how to gain control ... who actually is a popular relationship expert and coach. ... advices out there, Carrie worked at this program with Nick ... is a simple to use step by step method. This ...
(Date:8/29/2014)... 30, 2014 Cancer is a ... and caretakers. Author Eddie M. Leung knows the suffering that ... or bile duct cancer, a very rare and aggressive form ... My Life” (published by Xlibris), he shares a glimpse into ... imparts a survivor’s testimony that this disease can be overcome. ...
Breaking Medicine News(10 mins):Health News:First expert consensus on ventricular arrhythmias published 2Health News:First expert consensus on ventricular arrhythmias published 3Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 2Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 3Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 3
... - NUCRYST Pharmaceuticals,a developer and manufacturer of medical ... Wound Management division of Smith & Nephew,plc announced ... Flex barrier dressing for wounds that require up ... is a new addition to,the Acticoat(TM) family of ...
... medical home, personal health records and emergency,department coverage will ... conference presented by the Michigan State Medical Society (MSMS),on ... at The Inn at St. John,s,in Plymouth., State ... of the emerging health care model that ensures coordinated,patient ...
... Third Quarter Adjusted FIFO EBITDA Increases 9.5% to $21.2 Million , ... Same-Store Sales Grow by 3.7% , Gross Margin Improves ... to $22.1 Million in the Third,Quarter of 2007 , NEW ... for the third quarter ended September 27, 2008., Third Quarter ...
... Supplements Offers Tips on Expressing Gratitude,and Staying Active, ... Nutrition,International, one of the most trusted and respected ... 70 years, has declared the,month of November to ... to elevate widespread appreciation for America,s mature adults, ...
... expansion in the worldwide embedded database market Birdstep has entered into ... of Birdstep,s Raima Database Manager Product Family. , ... ... today announced they have completed an agreement with the TACT Group ...
... inflicting pain on others, research using brain scans at the ... brains showed that an area that is associated with rewards ... someone inflicting pain on another person. Youth without the ... showed. , "This is the first time that fMRI scans ...
Cached Medicine News:Health News:New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada 2Health News:New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada 3Health News:New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada 4Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 2Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 3Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 4Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 5Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 6Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 7Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 8Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 9Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 10Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 11Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 12Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 13Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 14Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 15Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 16Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 17Health News:Duane Reade Holdings, Inc. Reports Third Quarter Results 18Health News:Schiff(R) Nutrition International Declares November 'Give Thanks for Grandparents Month' 2Health News:Birdstep Technology Announced the Addition of the TACT Group to its Family of Distributors 2Health News:Birdstep Technology Announced the Addition of the TACT Group to its Family of Distributors 3Health News:Bullies may enjoy seeing others in pain 2
... HIBICLENS bonds with the ... protective, germ-killing field. In ... acting antimicrobial effect, HIBICLENS' ... potential promotes compliance with ...
... solution, allows the user to prep one ... in less than 2-minutes. It also utilizes ... surgical scrubbing and healthcare personnel handwashing. ACTIPREP ... provide a tacky surface for drapes to ...
... This multi-purpose topical gel contains 10% Povidone ... germicidal action. As a pre-operative prep, Povidone ... of prepping solutions under the patient, thus ... Gel is also approved as a one ...
... Scrub is a gentle and effective surgical ... dryness. Povidone Iodine is known to kill ... bacteria, fungi, viruses, protozoa and yeasts. It ... step in patient pre-operative prepping, as well ...
Medicine Products: